Advertisement

An improved HPLC method for analysis of methamphetamine and its metabolites in plasma

  • Ning-Yuan Li
  • Yan Li
  • Edward M. Sellers
Article

Summary

An improved HPLC method for analysis of methamphetamine (MAMP) and its metabolites in plasma was established, which features: high and reliable extraction recovery without loss of the analytes during solvent evaporation; no need for sample derivatization, and simultaneous analysis of MAMP, its N-demethylation and 4-hydroxylation metabolites. The major modification on the previous extraction procedure is addition of HCl to ethyl acetate extract prior to evaporation, resulting in significant increases in recovery, reproducibility and sensitivity. HPLC analysis is performed with an isocratic system on a C6 column. Samples are eluted with a mobile phase of acetonitrile-10 mM phosphate buffer containing 0.1% triethylamine (pH 6) at a flow rate of 1.0 ml/min, and monitored by a UV detector at a wavelength of 214 nm. All the analytes elute within 24 min. This method was successfully applied to the analysis of MAMP and its metabolites in rat plasma after MAMP dosing.

Keywords

Methamphetamine metabolites HPLC extraction plasma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Cho A.K. (1990): Ice: a new dosage form of an old drug. Science, 249, 631–634.CrossRefPubMedGoogle Scholar
  2. 2.
    Gonzalez F.J., Meyer U.A. (1991): Molecular genetics of the debrisoquine-sparteine polymorphism. Clin. Pharmacol. Ther., 50, 233–238.PubMedGoogle Scholar
  3. 3.
    Meyer U.A., Skoda R.C., Zanger U.M. (1990): The genetic polymorphism of debrisoquine/sparteine metabolism-molecular mechanisms. Pharmacol. Ther., 46, 297–308.CrossRefPubMedGoogle Scholar
  4. 4.
    Lin L.Y., Kumagai Y., Hiratsuka A., et al. (1995): Cytochrome P4502D isozymes catalyze the 4-hydroxylation of methamphetamine enantiomers. Drug Metab. Dispos., 23, 610–614.PubMedGoogle Scholar
  5. 5.
    Yamada H., Baba T., Hirata Y., Oguri K., Yoshimura H. (1984): Studies on N-demethylation of methamphetamine by liver microsomes of guinea-pigs and rats: the role of flavin-containing mono-oxygenase and cytochrome P-450 systems. Xenobiotica, 14, 861–866.CrossRefPubMedGoogle Scholar
  6. 6.
    Baba T., Yamada H., Oguri K., Yoshimura H. (1988): Participation of cytochrome P-450 isozymes in N-demethylation, N-hydroxylation and aromatic hydroxylation of methamphetamine. Xenobiotica, 18, 475–484.CrossRefPubMedGoogle Scholar
  7. 7.
    Cheung S., Nolte H., Otton S.V., Tyndale R.F., Wu P.H., Sellers E.M. (1997): Simultaneous gas chromatographic determination of methamphetamine, amphetamine and their p-hydroxylated metabolites in plasma and urine. J. Chromatogr., 690, 77–87.CrossRefGoogle Scholar
  8. 8.
    Ferrara S.D., Tedeschi L., Frison G., Castagna F. (1992): Solid-phase extraction and HPLC-UV confirmation of drugs of abuse in urine. J. Anal. Toxicol., 16, 217–222.PubMedGoogle Scholar
  9. 9.
    Legua C.M., Falco P.C., Cabeza A.S. (1995): Amphetamine and methamphetamine determination in urine by reversed-phase high-performance liquid chromatography with sodium 1,2-naphthoquinone 4-sulfonate as derivatizing agent and solid-phase extraction for sample clean-up. J. Chromatogr., 672, 81–88.CrossRefGoogle Scholar
  10. 10.
    Campins-Falco P., Seviliano-Cabeza A., Molins-Legua C. (1994): Amphetamine and methamphetamine determinations in biological samples by high performance liquid chromatography. A review. J. Liquid Chromatogr., 17, 731–747.CrossRefGoogle Scholar
  11. 11.
    O’Brien J.E., Zazulak W., Abbey, V., Hinsvark O. (1972): Determination of amphetamine and phentermine in biological fluids. J. Chromatogr. Sci. 10, 336–341.PubMedGoogle Scholar
  12. 12.
    Hornbeck C.L., Czarny R.J. (1989): Quantitation of methamphetamine and amphetamine in urine by capillary GC/MS. Part I. Advantages of trichloroacetyl derivatization. J. Anal. Toxicol., 13, 144–149.PubMedGoogle Scholar
  13. 13.
    Kobayashi S., Murray S., Watson D., Sesardic D., Davies D.S., Boobis A.R. (1989): The specificity of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in the rat is the inverse of that in man. Biochem. Pharmacol., 38, 2795–2799.CrossRefPubMedGoogle Scholar
  14. 14.
    Hiroi T., Ohishi N., Imaoka S. et al. (1995): Mepyramine, a histamine H1 receptor antagonist, inhibits the metabolic activity of rat and human P450 2D forms. J. Pharmacol. Exp. Ther., 272, 939–944.PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1997

Authors and Affiliations

  • Ning-Yuan Li
    • 1
    • 2
    • 3
    • 4
  • Yan Li
    • 1
    • 2
    • 3
    • 4
  • Edward M. Sellers
    • 1
    • 2
    • 3
    • 4
  1. 1.Department of Pharmacology, Room 4334, Medical Sciences BuildingUniversity of TorontoTorontoCanada
  2. 2.Department of Medicine and PsychiatryUniversity of TorontoTorontoCanada
  3. 3.Department of Psychopharmacology and Dependence Research Unit, Centre for Research in Women’s HealthWomen’s College HospitalTorontoCanada
  4. 4.Addiction Research FoundationTorontoCanada

Personalised recommendations